Virtual Medicinal Product (VMP) - Dolutegravir 50mg / Lamivudine 300mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Dolutegravir 50mg / Lamivudine 300mg tablets | Start Date 22-07-2019 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- J05AR25
- BNF Codes
-
- BNF code 05030100
| Code | Start Date | End Date |
|---|---|---|
| 37531111000001103 | 22-07-2019 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Dolutegravir sodium | Based on Base Substance | Dolutegravir | 50 mg | |
| Lamivudine | Based on Ingredient Substance | 300 mg |
Name
Lamivudine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
300
Strength and UOM (Dmr)
Name
Dolutegravir sodium
Basis of strength description
Based on Base Substance
BOSS
Dolutegravir
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
Parent Products
-
VTMLamivudine + Dolutegravir
-
VMP(Current) Dolutegravir 50mg / Lamivudine 300mg...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 30 tablet |